TimeTeller puts our internal clocks at the center of personalized medicine
- ID
- 35500
- Status
- summarized
- Published
- 15 Oct 2026, 4:00 AM
- Fetched
- 15 Oct 2026, 4:22 AM
- Provider
- TechCrunch
- Category
- technology
- Original URL
- https://techcrunch.com/2026/10/14/timeteller-puts-our-internal-clocks-at-the-center-of-personalized-medicine/
- Source URL
- https://techcrunch.com/feed/
Summary
- Score
- 3.0
- Created
- 15 Oct 2026, 4:23 AM
- Tags
- Audience
- saas_startup_founders
What happened
TechCrunch reports that German startup TimeTeller has begun taking direct orders for a saliva test kit that measures a person’s circadian rhythm, driven by demand from longevity clinics that use the data for personalized sleep, nutrition, light-exposure, and activity advice. CEO Angela Relógio, described as a physicist-engineer and molecular biologist, says the consumer kit cannot tell patients when to time cancer treatment; that requires calculating timing per medicine in clinical studies. The long-term goal is to use circadian biology to reduce side effects and improve outcomes in cancer, with possible applications in metabolic, neurodegenerative, performance, and women’s health.
Why it matters
For SaaS/startup founders in health tech, the concrete takeaway is that TimeTeller is selling a wellness-oriented DTC data product while explicitly separating it from clinical treatment-timing claims—so any similar product should avoid marketing per-medicine timing without clinical evidence. It also signals longevity clinics as an early B2B2C channel for personalized circadian data.
Discussion angle
Where should DTC health products draw the line between wellness advice and clinical claims? TimeTeller’s CEO says the kit can’t calculate per-medicine treatment timing outside clinical studies—should founders treat that as a regulatory constraint or a product opportunity?